Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-28 @ 12:30 AM
Study NCT ID:
NCT01578668
Status:
COMPLETED
Last Update Posted:
2015-01-26
First Post:
2012-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Sponsor:
Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GZTO1201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None